Dannuo Pharmaceutical-B (06872.HK): Formulates 2026 H-Share Award Scheme

Zhitong Finance APP News, TenNor Therapeutics-B (06872.HK) announced that, in order to further establish and improve a long-term incentive mechanism, attract and retain outstanding talent, fully mobilize employees' enthusiasm and creativity, enhance employee cohesion and the company's core competitiveness, and thereby bring sustained growth in investment returns to the majority of investors, effectively align the interests of the company's shareholders, the company, and the individual interests of the incentive recipients, and promote the company's long-term, sustainable, and healthy development, the board of directors has agreed to formulate an H-share scheme.